• 19-Feb-2026 Technegas US Footprint Expanding Across Four Regions Technegas US Footprint Expanding Across Four Regions
• 18-Feb-2026 Technegas Approved at the US National Institutes of Health Technegas Approved at the US National Institutes of Health
• 13-Feb-2026 Becoming a substantial holder Becoming a substantial holder
• 12-Feb-2026 Share Purchase Plan Offer Booklet Share Purchase Plan Offer Booklet
• 11-Feb-2026 Cleansing Notice Cleansing Notice
• 11-Feb-2026 Application for quotation of securities - CYC Application for quotation of securities - CYC
• 4-Feb-2026 Proposed issue of securities - CYC Proposed issue of securities - CYC
• 4-Feb-2026 Cyclopharm Capital Raising Investor Presentation Cyclopharm Capital Raising Investor Presentation
• 4-Feb-2026 Cyclopharm Successfully Completes A$14 million Placement Cyclopharm Successfully Completes A$14 million Placement
• 2-Feb-2026 CYC Unaudited Trading Update - Preliminary FY2025 Results CYC Unaudited Trading Update - Preliminary FY2025 Results
• 2-Feb-2026 Trading Halt Trading Halt
• 29-Jan-2026 COPD Study Leveraging Technegas and AI-Driven Lung Analysis COPD Study Leveraging Technegas and AI-Driven Lung Analysis

Click here for archives